首页> 外国专利> HEPATITIS B VIRUS EPITHOPES INCLUDED IN THE RESPONSE OF CYTROXIC T-LYMPHOCYTES (CTL) RESTRICTED FOR HLA.

HEPATITIS B VIRUS EPITHOPES INCLUDED IN THE RESPONSE OF CYTROXIC T-LYMPHOCYTES (CTL) RESTRICTED FOR HLA.

机译:乙型肝炎病毒乙型肝炎病毒表位包括限制HLA的细胞毒性T淋巴细胞(CTL)的反应。

摘要

STIMULATING PEPTIDES OF CYTOTOXIC T-LYMPHOCYTE INDUCTING ANSWERS TO HEPATITIS B VIRUS ANTIGENS RESTRICTED TO HLA. THE PEPTIDES, DERIVED FROM THE EPITOPIC REGIONS OF THE CTL BOTH OF THE HBV SURFACE AND THE NUCLEOCAPSID ANTIGENS, ARE PARTICULARLY USEFUL IN THE TREATMENT AND PREVENTION OF THE INFECTION CAUSED BY THE HBV, INCLUDING THE TREATMENT OF CARRIERS OF HBV CARRIERS. PEPTIDES CAN BE FORMULATED AS VACCINES AND PHARMACEUTICAL COMPOSITIONS AGAINST HBV, SUCH AS COMPOSITIONS CONTAINING LIPIDS TO INTENSIFY THE CTL'S RESPONSES RESTRICTED TO HLA. PEPTIDES ARE ALSO USEFUL IN DIAGNOSTIC METHODS, SUCH AS THE PREDICTION THAT INDIVIDUALS INFECTED WITH HBV ARE PROPOSED TO DEVELOP A CHRONIC INFECTION.
机译:刺激限制HLA的乙型肝炎病毒抗原刺激细胞毒性T淋巴细胞的肽。源自HBV表面CTL的表位区域和核衣壳抗原的肽特别适用于治疗和预防HBV引起的感染,包括治疗HBV携带者。可以配制肽类作为针对HBV的疫苗和药物组合物,例如含有脂质的组合物,以强化CTL对HLA的要求。在诊断方法中,肽也是有用的,例如,建议用乙型肝炎病毒感染的个体进行慢性感染。

著录项

  • 公开/公告号ES2155060T3

    专利类型

  • 公开/公告日2001-05-01

    原文格式PDF

  • 申请/专利权人 EPIMMUNE INC.;

    申请/专利号ES19920307764T

  • 发明设计人 VITIELLO MARIA A.;CHESNUT ROBERT W.;

    申请日1992-08-26

  • 分类号C12N15/51;A61K39/29;G01N33/569;C07K7/00;

  • 国家 ES

  • 入库时间 2022-08-22 01:22:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号